Showing results (1-10 of 1,033) with videos related to
Sort By:
Pageof 104
Journal of Drugs in Dermatology : JDD|December 21, 2020
Time Intervals Until the First Return Office Visit After New MedicationsSuraj Muddasani, Courtney E Heron, Alan B Fleischer, et al.The Journal of Clinical and Aesthetic Dermatology|June 1, 2022
Trends in Office Visits for the Five Most Common Skin Diseases in the United StatesAyman Grada, Suraj Muddasani, Alan B Fleischer, et al.The Journal of Dermatological Treatment|February 13, 2020
United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitorsSuraj Muddasani, Alan B FleischerThe Journal of Dermatological Treatment|October 6, 2020
Dermatologists are increasing their use of non-opioid pain medications faster than opioidsSuraj Muddasani, Gabrielle Peck, Alan B FleischerJournal of Cutaneous Medicine and Surgery|January 28, 2021
Sanitation, Obesity, and Low Body Mass Index as Risk Factors for Bacterial Skin InfectionsPushkar Aggarwal, Suraj Muddasani, Alan B FleischerThe Journal of Dermatological Treatment|April 3, 2020
An assessment of United States dermatology practices during the COVID-19 outbreakSuraj Muddasani, Anne Housholder, Alan B FleischerThe Journal of Dermatological Treatment|July 22, 2021
Treatment of nail diseases in the emergency departmentMike Fritz, Suraj Muddasani, Alan B FleischerJournal of Drugs in Dermatology : JDD|December 5, 2023
The Persistence of Nystatin Use for Dermatophyte InfectionsSuraj Muddasani, Gabrielle Rivin, Alan B FleischerThe Journal of Dermatological Treatment|September 17, 2020
An assessment of current practices in the treatment of hidradenitis suppurativa: the rise of biologic therapySuraj Muddasani, Kelsey S Flood, Alan B FleischerCutis|June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implicationsSteven R Feldman, Alan B FleischerPageof 104